BioSpace News Archive

Business

BioSpace Movers & Shakers, March 25

Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.

March 24, 2022
·
7 min read
·
Alex Keown
Drug Development

Jazz Doses First Patient in Broad Trial for Promising Cancer Drug

The Phase II trial is evaluating zepzelca as a monotherapy in patients with urothelial carcinoma, large cell neuroendocrine carcinoma of the lung and HRD tumors.

March 24, 2022
·
3 min read
·
Hayley Shasteen
Drug Development

Stalled by COVID-19, TB Research Needs to Make Up for Lost Time

In honor of March 24, World TB Day, BioSpace looks at clinical trials and eradication efforts occurring today.

March 24, 2022
·
5 min read
·
Rosemary Scott
Policy

Automation in Pharmaceutical Industry Makes it a Prime Target for Cyber Attacks: Be Ready

Automation in pharmaceutical industry can make the companies target of the cyber threats emanating from Russia, China, and North Korea. It can be collateral or direct.

March 24, 2022
·
5 min read
·
Gail Dutton
Policy

U.S. Judge Tosses Genentech Lawsuit Against Sandoz

A federal judge in Delaware tossed out a lawsuit by Genentech, Inc., a Roche company, accusing Novartis’ Sandoz division of patent infringement.

March 24, 2022
·
3 min read
·
Mark Terry
Pixium Vision to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest on March 28 - 30

Pixium Vision SA announces that Lloyd Diamond, Chief Executive Officer of Pixium Vision, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest from March 28 to 30, 9.00 am to 5.00 pm EDT / 3.00 pm to 11.00 pm CET.

March 24, 2022
·
2 min read
Business

Valneva Reports Full Year 2021 Results and Provides Corporate Updates

Saint-Herblain, March24, 2022 – Valneva SE, a specialty vaccine company, reported its audited consolidated financial results for the year ending December 31, 2021 and provided corporate updates.

March 24, 2022
·
17 min read
Addex to Present at the Bio-Europe Spring 2022 and Maxim Group – 2022 Virtual Growth Conferences

Addex Therapeutics announced that CEO, Tim Dyer, will present at both the Bio-Europe Spring 2022 Conference and the Maxim Group – 2022 Virtual Growth Conference taking place March 28 - 31, 2022 and March 28 – 30, 2022, respectively.

March 24, 2022
·
3 min read
Business

Innate Pharma Reports Full Year 2021 Financial Results and Business Update

Innate Pharma SA reported its consolidated financial results for the year ending December 31, 2021.

March 24, 2022
·
40 min read
Sensorion Provides Preliminary Documents for the Extraordinary General Meeting of April 14th, 2022

Sensorion announces that the Company’s shareholders are invited to participate in the Extraordinary General Meeting, to be held on Thursday, April 14th, 2022, at 2 pm CET in the premises of the hotel L’Arcade, located at 9 rue de l’Arcade, 75008, Paris.

March 24, 2022
·
4 min read